Centrum 7/6  banner

The Inflation Reduction Act’s impact on biosimilars

The Inflation Reduction Act’s impact on biosimilars

The Inflation Reduction Act (IRA), which was signed into law in August of 2022, announced several provisions on prescription drugs, with the aim of lowering the burden on people and reducing federal spending on drugs. Some of these provisions are targeted at high-cost biologic drugs and are in turn expected have a profound impact on

PP_1170x120_10-25-21